Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 7CNS 7Breast 7Thoracic 5Gastrointestinal 5Dermatologic 4Tumor-Agnostic 3Genitourinary 3Sarcoma 2Head & Neck 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 3Carcinoma 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Vaccines × Tumor-Agnostic × Clear all
NCT04948619 2026-01-22

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

Wake Forest University Health Sciences

Phase 2 Recruiting
64 enrolled
Tumor-Agnostic

Neoplasms

NCT00505063 2025-06-15

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
76 enrolled
Tumor-Agnostic

Neoplasms

NCT00684294 2020-03-02

Auto TAG

Mary Crowley Medical Research Center

Phase 1 Terminated
46 enrolled
Tumor-Agnostic

Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡